Skip to content
New StartMD
Open menu
The evidenceGrade D · Preclinical only — no human efficacy trials

DSIP

Also known as Delta Sleep-Inducing Peptide

A peptide named for sleep effects, but with sparse, inconsistent, and dated human data.

Available to orderSee DSIP in the catalog

What the studies found

Each line is a plain-English summary of a real study. Follow the link to read the primary source yourself.

  • A review of delta-sleep-inducing peptide summarizes its proposed biology and the limited, inconsistent early human data; its sleep role is poorly established.

How it works

Proposed sleep/neuromodulatory effects; no established receptor or mechanism.

Doses & safety

Studied doses. No reliable modern human dosing exists.

Safety. Essentially no reliable modern human safety data; its sleep benefit is unproven.

Go deeper

The full picture

The complete, plain-English review — what it is, what people use it for, how it works, what the research actually looked at, and who it's not for.

What it is

DSIP is a short chain of nine amino acids, first identified in the 1970s in research on sleep physiology. Its name comes from what researchers were studying at the time: delta sleep, the deepest and most physically restorative stage of the night. It is used by people looking to improve the quality of their sleep rather than simply the number of hours — the difference between time spent in bed and waking up feeling like the night actually did something restorative.

What people use it for

USED FORWHAT THAT MEANS
Deeper, more restorative sleepThe use it was named for, explored in a small body of early human research.
Falling asleep more easilyReported in the same research. It is not a sedative.
Stress and recoveryBased on how it appears to interact with stress-hormone rhythms.

How it works

DSIP was first isolated in laboratory research on sleep-inducing substances, and early research proposed that it interacts with the body's stress-hormone and sleep-regulating systems. Unlike a sedative, it is not thought to act on the same receptors as prescription sleep medications.

The proposed mechanism involves influence over the deeper stages of the sleep cycle rather than simply causing drowsiness, which is the basis for it being described as improving sleep quality rather than sleep quantity. This mechanism has not been mapped with the same precision as it has for approved sleep medications.

What the research actually looked at

The original human research behind DSIP, dating to the 1970s and 1980s, is a small body of early studies exploring delta sleep and ease of falling asleep. That research is decades old and has not been repeated to modern clinical-trial standards.

A stress-and-recovery use is sometimes proposed based on how DSIP appears to interact with stress-hormone rhythms, but this rests on theory rather than dedicated human study. No large-scale, modern, controlled human trial of DSIP for sleep, stress, or any other use has been published.

Common misunderstandings

  • “It's a sedative.” DSIP is not thought to act the way prescription sleep medications do; it does not appear to work through the same sedating mechanism.
  • “It's backed by modern clinical trials.” The human research behind DSIP dates to the 1970s and 1980s and has not been replicated to current standards.
  • “It can replace treatment for a real sleep disorder.” Chronic insomnia, sleep apnea, and narcolepsy are conditions with their own evaluated treatments; DSIP is not a substitute for diagnosing and treating an underlying sleep disorder.
  • “The stress-recovery benefit is established.” That use is theoretical, based on how DSIP is thought to interact with stress-hormone rhythms, not on dedicated human trials.

Who it is not for

  • Anyone with chronic insomnia or narcolepsy who would use this in place of an evaluated treatment — approved options exist for both.
  • Anyone with an immune or allergic history, where an injectable is proposed.
  • Pregnant or breastfeeding women, and anyone under 18.
  • Anyone already taking sedatives or sleep medication, without discussing it first. Competitive athletes: DSIP is not currently named on the WADA Prohibited List. Athletes in tested sport should still confirm current status with their sport's anti-doping authority before use, given the contamination risk inherent to compounded peptide products.

Who makes this, and under what rules

Everything dispensed here is prepared by a licensed 503A compounding pharmacy — not bought from a supplier and repackaged, and not sourced from an online seller. That designation carries specific, enforceable obligations:

  • A prescription in your name. Compounded from a prescription for one identified patient, after an evaluation.
  • Licensed and inspected. A state license, subject to inspection by the state board of pharmacy.
  • Sterile preparation to a published standard. USP standards.
  • A paper trail. A lot number and beyond-use date on every preparation.

A compounded preparation is not an FDA-approved medicine — but it is the difference between a licensed pharmacy working to a standard and an unregulated website.

Where this stands

Never approved anywhere. Identified in the 1970s. Human research is old and sparse. Decades old, not replicated to modern standards. A compound known about for fifty years with almost no modern trial data is telling you something.

Clinical detail

A nine-amino-acid peptide first identified in the 1970s in sleep research, first isolated in laboratory research. Named for delta sleep, the deepest, most physically restorative stage of non-REM sleep. Not thought to act on the same receptors as prescription sedative or hypnotic medications. Human research is limited to small studies from the 1970s-1980s, not repeated to modern trial standards. No large-scale modern controlled human trial has been published for sleep, stress, or any other proposed use.

The information on this page is general education. It is not medical advice and it is not a recommendation for any treatment. DSIP is not an FDA-approved medicine for the uses described here. A compounded preparation is not an FDA-approved product and has not been reviewed by the FDA for safety, effectiveness or quality. Descriptions of what this is used for reflect how it is commonly used and discussed. They are not claims that it is effective for any purpose. Any prescription follows an individual evaluation by a licensed provider and is issued only where that provider judges it clinically appropriate. A prescription is never guaranteed.

This page summarizes published research so you can read it yourself. It is education, not medical advice or a recommendation, and grades describe the evidence, not a promise of results. A licensed provider decides whether anything here is appropriate for you.

Products are available only by prescription after a consultation with a licensed provider, who decides whether treatment is appropriate. Many compounds described here are not FDA-approved medicines and have not been tested in people for the uses described; information on this site is educational and is not medical advice.